Two posters presented at the American College of Allergy, Asthma and Immunology 2023 Annual Scientific Meeting evaluated real-world biologic utilization for patients with severe, uncontrolled asthma.

Biologics for the treatment of asthma were first introduced about 20 years ago. Since then, more and more people with asthma have found them to be an effective treatment in getting their symptoms ...

The introduction of respiratory biologics shows greatest benefits in patients with severe and eosinophilic asthma.

Poorly controlled asthma during pregnancy can lead to serious complications, such as low birth weight, preterm delivery, and preeclampsia. For individuals with severe asthma, biologics—a new type of ...

Asthma causes inflammation and narrowing of the airways, making it harder to breathe. Symptoms may include wheezing, coughing, chest tightness, and shortness of breath. These symptoms can vary in ...

The latest advances in asthma care combine revolutionary biologics, individualized immunotherapy, and targeted treatments that address specific triggers, ditching the “one-size-fits-all” approach. The ...

Please provide your email address to receive an email when new articles are posted on . A 50% or greater reduction in exacerbation rate was one of the four criteria for response. Criteria also ...

The introduction of biologic therapies for severe asthma has transformed clinical practice. Among these agents, benralizumab ...

Please provide your email address to receive an email when new articles are posted on . The cohort included patients aged 12 years and older diagnosed with severe asthma. There were lower incidence ...

A monthly injection has helped 90% of severe asthma patients reduce daily steroid tablets, which are associated with long-term side effects. More than half of the participants who had received the ...

Adults with severe asthma were more likely to discontinue biologic therapy based on nonclinical reasons than based on side effects or perceived ineffectiveness, according to data from more than 7000 ...